Seadrill Transocean Most Requested Fund Quotes Fidelity Contrafund Vanguard Wellington Vanguard Dividend Growth Vanguard 500 Vanguard Health Care Most Requested Fund Analyses Dodge & Cox International Stock T. Rowe Price Diversified Small Cap Growth Vanguard Wellington
3%, so 33% is managed by Wellington Management. We like their style. Now, we are considering adding maybe 5-10% of VGHCX (managed by Wellington) to the portfolio and wonder if that would be too much overlap of holdings that are already covered
VGHCX and other HC funds have outperfomed for a few years now compared to the S&P; from what I read a lot of that was due to anticipated Obamacare signups. With the Republicans vowed to attack Obamacare, is it time to pull back on H.C. allocaton?
On 4/2/14, a Moningstar new item stated that VGHCX was upgraded from 3 to 4 stars. However your data base still has 3 stars for VGHCX .
I am having difficulty deciding where would be more tax efficient to add VGHCX ( Vanguard Health Care ), taxable account or IRA account? Turnover rate 21%. TCA 1.4 -2.8. Would appreciate your comments.
Ticker Name % VWIAX Wellesley 31% VWENX Wellington 24% VGSTX STAR 3% VTI Tot Stk M 14% VBR SC Value 5% VOE MC Value 5% DODFX Intn'l 4% VGHCX Health 5% VGENX Energy 4% VDIGX Div 2% PONDX Bnd Multi 2% LSBRX Bnd Retail 1% 100%
I am looking for ideas on Health Care funds, to hold long term. I started looking at VG Health Care fund ( VGHCX ) and TRowe (PRHSX). I was thinking of adding both, however, their stock intersection seems to be a little much (or not
performance. Some of the best were: Fund Total Loss Months to recover VWINX 18% 23 JANBX 21% 25 FBIOX 29% 31 VWELX 32% 39 VGHCX 32% 40 Some of the worse: DODGX 59% 60 DODWX 62% 57 FSAIX 61% 62 FSRBX 67% 83 FRESX 71% 73 All the data needed to check
sensor makers: InvenSense, MediaTek, NXP Semi, OmniVision, QuickLogic Pg 24: Jean Hynes , manager of Vanguard healthcare VGHCX since Jan 2013, has made some portfolio adjustments – less cash, more holdings, more biotechs. It has value orientation and
prospectuses. Pg L13: Biotech is a growth area within the healthcare sector. Mentioned are FSPHX, JFNAX, PHLAX, PRHSX, VGHCX . Pg L15: Many new bond ETFs are coming and the investors are cautioned about the very specialized bond ETFs [for illiquid